Breast Carcinoma
Item
documented diagnosis of breast cancer
boolean
C0678222 (UMLS CUI [1])
Menstrual cycle Last | Past Year Quantity
Item
last menstrual period occurring more than 5 years ago
boolean
C0025329 (UMLS CUI [1,1])
C1517741 (UMLS CUI [1,2])
C1444637 (UMLS CUI [2,1])
C0439234 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
Breast Carcinoma TNM clinical staging
Item
non-metastatic breast cancer tumor with the diagnosis of tis, tl-t4, n0-3, m0
boolean
C0678222 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
Noninfiltrating Intraductal Carcinoma | Lobular carcinoma in situ of breast
Item
dcis is allowed, but lcis (only) is not
boolean
C0007124 (UMLS CUI [1])
C0279563 (UMLS CUI [2])
Metabolic Bone Disorder | Osteoporosis, Postmenopausal | Osteopenia Postmenopausal
Item
any metabolic bone disease other than postmenopausal osteoporosis or osteopenia
boolean
C0005944 (UMLS CUI [1])
C0029458 (UMLS CUI [2])
C0029453 (UMLS CUI [3,1])
C0232970 (UMLS CUI [3,2])
Pharmaceutical Preparations Gonadal Hormones Systemic | Supplement Gonadal Hormones Systemic
Item
use of systemic gonadal hormonal medications or supplements within the past 24 months
boolean
C0013227 (UMLS CUI [1,1])
C0301819 (UMLS CUI [1,2])
C0205373 (UMLS CUI [1,3])
C2348609 (UMLS CUI [2,1])
C0301819 (UMLS CUI [2,2])
C0205373 (UMLS CUI [2,3])
Tamoxifen Discontinued | Raloxifene Discontinued
Item
prior use of tamoxifen or raloxifene is permitted if the medication was discontinued more than 24 months prior to the diagnosis of breast cancer.
boolean
C0039286 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C0244404 (UMLS CUI [2,1])
C1444662 (UMLS CUI [2,2])
Antioestrogen therapy Adjuvant | Antineoplastic Drug/Agent Therapy Adjuvant
Item
no adjuvant antiestrogen, antineoplastic, therapies are permitted on study.
boolean
C0854638 (UMLS CUI [1,1])
C1522673 (UMLS CUI [1,2])
C2346834 (UMLS CUI [2,1])
C1522673 (UMLS CUI [2,2])
Systemic steroids chronic | Chemotherapy Premedication Breast Carcinoma | Antiemetics
Item
chronic use of systemic steroids for disease process other than breast cancer chemotherapy premedication or antiemetics
boolean
C2825233 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2,1])
C0033045 (UMLS CUI [2,2])
C0678222 (UMLS CUI [2,3])
C0003297 (UMLS CUI [3])
Rheumatoid Arthritis | Ankylosing spondylitis | Hyperparathyroidism | Renal Osteodystrophy | Inflammatory disorder Moderate | Inflammatory disorder Severe | Autoimmune Diseases Moderate | Autoimmune Diseases Severe | Thyroid Diseases Requirement Titration Pharmaceutical Preparations
Item
history of rheumatoid arthritis, ankylosing spondylitis, hyperparathyroidism, renal osteodystrophy, moderate to severe inflammatory or autoimmune disease or newly diagnosed thyroid condition requiring titration of medications.
boolean
C0003873 (UMLS CUI [1])
C0038013 (UMLS CUI [2])
C0020502 (UMLS CUI [3])
C0035086 (UMLS CUI [4])
C1290884 (UMLS CUI [5,1])
C0205081 (UMLS CUI [5,2])
C1290884 (UMLS CUI [6,1])
C0205082 (UMLS CUI [6,2])
C0004364 (UMLS CUI [7,1])
C0205081 (UMLS CUI [7,2])
C0004364 (UMLS CUI [8,1])
C0205082 (UMLS CUI [8,2])
C0040128 (UMLS CUI [9,1])
C1514873 (UMLS CUI [9,2])
C0162621 (UMLS CUI [9,3])
C0013227 (UMLS CUI [9,4])
Lobular carcinoma in situ of breast | Breast Carcinoma TNM clinical staging | Neoplasms, Second Primary | Skin carcinoma Treated | Carcinoma in situ of uterine cervix Treated
Item
lobular carcinoma in situ or stage iv breast cancer and patients with a concurrently active second malignancy other then adequately treated non-melanoma skin cancers or in situ cervical cancer.
boolean
C0279563 (UMLS CUI [1])
C0678222 (UMLS CUI [2,1])
C3258246 (UMLS CUI [2,2])
C0085183 (UMLS CUI [3])
C0699893 (UMLS CUI [4,1])
C1522326 (UMLS CUI [4,2])
C0851140 (UMLS CUI [5,1])
C1522326 (UMLS CUI [5,2])
Study Subject Participation Status | Bone Mineral Density Test
Item
participation in other clinical trials that are measuring bmd as a study parameter
boolean
C2348568 (UMLS CUI [1])
C0177804 (UMLS CUI [2])
Condition Interferes with Bone Mineral Density Test | Condition Interferes with DEXA Result
Item
patients with conditions that are expected to distort bmd reading and make dexa results unreliable
boolean
C0348080 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0177804 (UMLS CUI [1,3])
C0348080 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C1510486 (UMLS CUI [2,3])
C1274040 (UMLS CUI [2,4])
Medical condition Preventing Protocol Compliance | Mental condition Preventing Protocol Compliance
Item
patients with concurrent medical or psychiatric conditions that would keep them from understanding and complying with this clinical trial.
boolean
C3843040 (UMLS CUI [1,1])
C1292733 (UMLS CUI [1,2])
C0525058 (UMLS CUI [1,3])
C3840291 (UMLS CUI [2,1])
C1292733 (UMLS CUI [2,2])
C0525058 (UMLS CUI [2,3])